.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Covington
Baxter
McKesson
Fish and Richardson
Mallinckrodt
AstraZeneca
Healthtrust
Deloitte
Express Scripts

Generated: June 25, 2017

DrugPatentWatch Database Preview

CARBILEV Drug Profile

« Back to Dashboard

What is the patent landscape for Carbilev, and when can generic versions of Carbilev launch?

Carbilev is a drug marketed by Ranbaxy and is included in one NDA.

The generic ingredient in CARBILEV is carbidopa; levodopa. There are eighteen drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the carbidopa; levodopa profile page.

Summary for Tradename: CARBILEV

Patents:0
Applicants:1
NDAs:1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CARBILEV at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ranbaxy
CARBILEV
carbidopa; levodopa
TABLET, FOR SUSPENSION;ORAL076643-001Jun 10, 2005DISCNNoNo► Subscribe► Subscribe
Ranbaxy
CARBILEV
carbidopa; levodopa
TABLET, FOR SUSPENSION;ORAL076643-002Jun 10, 2005DISCNNoNo► Subscribe► Subscribe
Ranbaxy
CARBILEV
carbidopa; levodopa
TABLET, FOR SUSPENSION;ORAL076643-003Jun 10, 2005DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
US Army
Express Scripts
AstraZeneca
Covington
UBS
Deloitte
Merck
Novartis
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot